SanFlow is being developed to: (1) correct vascular dysfunction and inflammatory reactions (2) prevent organ injuries and death in brain injuries, hemorrhagic shock, cancer, stroke, Alzheimer's Disease, COVID-19 infections and other conditions. SanFlow’s use in Prolonged Field Care, the top priority capability gap across the US Army, is highlighted.
Primary Application Area: Healthcare & Medical Devices
Technology Development Status: Proven Manufacturability
Technology Readiness Level: TRL 4
Organization Type: Mid-stage Startup (A or B)
GOVT/EXTERNAL FUNDING SOURCES